Tumor-bearing mice cured of CT26 tumors were rechallenged after 100 days with CT26 and 4T1 on opposing flanks.
收藏NIAID Data Ecosystem2026-03-09 收录
数据链接：
官方服务：
资源简介：
Resulting tumor growth demonstrated all mice cured of CT26 rejected rechallenge with CT26, but succumbed to syngeneic, but immunologically distinct 4T1 tumors.
创建时间：
2016-06-13
